The EU Mission on Cancer aims to optimise the diagnostic and treatment and support the quality of life of cancer patients. It also focuses on preventing this life-threatening disease from affecting millions in the EU.
On 12 January 2023, HaDEA launched a call for proposals under the Horizon Europe programme to contribute to the swift implementation of the EU Cancer Mission.
13 projects were shortlisted for a total funding of €110.7 million. The projects involve 238 research teams from 30 countries in Europe and beyond to:
-
Address poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients (€36.68 million);
-
Enhance primary cancer prevention through sustainable behavioural change (€25 million);
-
Conduct pragmatic clinical trials on minimally invasive diagnostics (€43 million);
-
Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions (€6 million).
13 research projects selected for funding to support the EU Mission on Cancer
|
Acronym |
Title |
Coordinating organisation |
Participating countries |
| Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients | |||
|
Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and |
INSTYTUT BIOLOGII DOSWIADCZALNEJ IM. M. NENCKIEGO POLSKIEJ AKADEMII NAUK |
11 partners: CA (2), DE, FR (2), IL, IT, NL, PL (2), UK |
|
|
Tumour-host interactions in liver cancer of childhood and adults |
FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER |
13 partners: BE, CH, DE (3), ES (3), FR, IL, IT, UK (2) |
|
|
The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics |
KATHOLIEKE UNIVERSITEIT LEUVEN |
15 partners: BE (4), CH, DE, ES (2) IL, IT, NL (2), NO, SE, UK |
|
|
MULti-Tumour based prediction and manipulation of Immune Response |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE |
17 partners: AT, CA, CH, DE (2), DK, EL (3), ES, FR (3), HR, IE, NO, NL |
|
| Enhancing primary cancer prevention through sustainable behavioural change | |||
|
SUstaiNable inteRventions and healthy behavIours for adoleScent primary prEvention of cancer with digital tools |
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS |
19 partners: AU, BE (2), CH, CY, EE, EL (4), ES (4), IT, PT, RO (2), SI |
|
|
Multimodal Engagement and sustainable Lifestyle Interventions Optimizing breast cancer Risk reduction supported by Artificial intelligence |
CHAROKOPEIO PANEPISTIMIO |
16 partners: BE (2), DE, EL (4), ES (4), SE (2), LT (2), PL |
|
|
IBeCHANGE - Addressing Psychosocial and lifestyle risk factors to promote primary cancer prevention: an integrated platform to promote behavioural change |
ISTITUTO EUROPEO DI ONCOLOGIA SRL |
12 partners: BE, EE, ES (2), IT (3), NL, RO (2), SI, UK |
|
| Conducting pragmatic clinical trials on minimally invasive diagnostics | |||
|
Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe |
MEDIZINISCHE HOCHSCHULE HANNOVER |
21 partners: DE (8), FR, EL, ES, IL, IT (5), NL (3), PL |
|
|
Personalised response monitoring in oncology: co-creating clinical trials in advanced breast cancer |
REGION SYDDANMARK |
13 partners: AT, CH, DE, DK (5), IT (3), SE, UK |
|
|
Endoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for detecting cost effective surveillance strategies and prediction of cancer recurrence |
UNIVERSITEIT ANTWERPEN |
13 partners: BE (2), ES, FR, DE (2), IE, IT, NL (3), SE (2) |
|
|
Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer |
FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER |
18 partners: AT (2), CH (2), DE, ES (5), FR, IT (4), IE, IL, NL |
|
|
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis |
SIOP EUROPE |
25 partners: AT (6), BE (4), CZ, DE (2), EL (2), ES, FR (2), IE, IT, NL (2), UK (3) |
|
| Establishing best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions | |||
|
e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia |
GCS HUGO |
32 partners: BA, BE, DE (2), CH, DK (2), ES, FI (2), FR (10), HU (2), HR, NL, NO (2), IT (2), RO (2), SL, UK |
|